Literature DB >> 12743864

[MR-guided biopsies of undetermined liver lesions: technique and results].

S Zangos1, D Kiefl, K Eichler, K Engelmann, M Heller, C Herzog, M G Mack, V Jacobi, T J Vogl.   

Abstract

PURPOSE: To evaluate safety and precision of liver tumor biopsies performed in an open low field system using different sequence techniques.
MATERIALS AND METHODS: In 47 patients with liver tumors, MR-guided biopsies were performed in a low field system (0.2 Tesla, Magnetom Open, Siemens) using two different sequences. The procedure was monitored with T1-weighted FLASH sequences (TR/TE = 100/9; 70(3)) in all patients and with FISP-Rotated-Keyhole-sequence (TR/TE = 18/8; 90(3)) in additional 20 patients. After positioning of the needle tip in the tumors, 166 biopsy specimens were acquired with 16 G cutting needles (Somatex*). The diameter of the biopsied lesions ranged from 1 to 10 cm (mean diameter 3.2 cm). Visibility of the needles and precision of the biopsies were evaluated.
RESULTS: All interventional biopsies were performed without vascular or organ injuries. Adequate specimens for histologic interpretation were obtained in 42 cases (89.3%). The biopsy results were non-specific in 2 patients (4.2%) and the lesions missed in 3 patients (6.3%). Mean in-room time was 35 minutes and the intervention time was 8.3 minutes. T1-weighted FLASH images proved optimal for confirming needle-tip placement during the biopsies or punctures. Organs, tumors and vessels were easily identified. The FISP sequence proved to be inferior in visualizing vessels and tumors.
CONCLUSION: MR-guided liver biopsies are safely and precisely performed using T1-weighted FLASH-sequences with sufficient visualization of the lesions and might be complementary to US- or CT-guided biopsies.

Entities:  

Mesh:

Year:  2003        PMID: 12743864     DOI: 10.1055/s-2003-39210

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  8 in total

1.  Magnetic resonance-guided upper abdominal biopsies in a high-field wide-bore 3-T MRI system: feasibility, handling, and needle artefacts.

Authors:  Jens-Peter Kühn; Sönke Langner; Katrin Hegenscheid; Matthias Evert; Antje Kickhefel; Norbert Hosten; Ralf Puls
Journal:  Eur Radiol       Date:  2010-05-26       Impact factor: 5.315

Review 2.  Interventional and intraoperative MR: review and update of techniques and clinical experience.

Authors:  Thomas Schulz; Silvia Puccini; Jens-Peter Schneider; Thomas Kahn
Journal:  Eur Radiol       Date:  2004-10-06       Impact factor: 5.315

3.  [Percutaneous liver biopsy. Overview of different techniques].

Authors:  J Kettenbach; M Blum; K El-RaBadi; H Langenberger; B Happel; J Berger; A Ba-Ssalamah
Journal:  Radiologe       Date:  2005-01       Impact factor: 0.635

4.  MR-guided liver biopsy within a short, wide-bore 1.5 Tesla MR system.

Authors:  Joerg Stattaus; Stefan Maderwald; Hideo A Baba; Guido Gerken; Joerg Barkhausen; Michael Forsting; Mark E Ladd
Journal:  Eur Radiol       Date:  2008-07-19       Impact factor: 5.315

5.  MR-guided biopsies with a newly designed cordless coil in an open low-field system: initial findings.

Authors:  Stephan Zangos; Theodor Vetter; Frank Huebner; Montu Tuwari; Florian Mayer; Katrin Eichler; M-L Hansmann; A Wetter; C Herzog; Thomas J Vogl
Journal:  Eur Radiol       Date:  2005-12-13       Impact factor: 5.315

6.  [Treatment and patient information in the context of uncertain diagnosis].

Authors:  Andreas Eichwalder
Journal:  Wien Med Wochenschr       Date:  2006-05

7.  MR-guided biopsies of lesions in the retroperitoneal space: technique and results.

Authors:  S Zangos; K Eichler; A Wetter; T Lehnert; R Hammerstingl; T Diebold; P Reichel; C Herzog; M-L Hansmann; M G Mack; T J Vogl
Journal:  Eur Radiol       Date:  2005-07-30       Impact factor: 5.315

8.  Navigated MRI-guided liver biopsies in a closed-bore scanner: experience in 52 patients.

Authors:  Michael Moche; Susann Heinig; Nikita Garnov; Jochen Fuchs; Tim-Ole Petersen; Daniel Seider; Philipp Brandmaier; Thomas Kahn; Harald Busse
Journal:  Eur Radiol       Date:  2015-11-12       Impact factor: 5.315

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.